On this page
- Why the answer is the same everywhere
- “Under supervision” does not change it, and this is where people get hurt
- What your licence does cover
- The scope map, in three tiers
- Can estheticians do microneedling?
- What a “medical esthetician” actually is
- Chemical peels, lasers and the rest of the middle tier
- What actually happens when scope is exceeded
- What those treatments are actually worth
- The treatments you cannot perform can still be yours to offer
- Three ways to add what you cannot perform
- Where we sit
No, and not in any state. Botox is a prescription drug, injecting it is the practice of medicine, and an esthetician licence is issued by a cosmetology board that does not confer either. This is not a rule waiting to be relaxed, it is a consequence of what the licence is. What varies by state, sometimes a lot, is everything below the needle.
Why the answer is the same everywhere
Most scope questions have fifty answers. This one has one, and understanding why saves you asking it again about the next treatment.
Two separate things have to be true before anyone can inject botulinum toxin. It is a prescription drug, so a licensed prescriber has to authorise it for a specific patient. And injecting it is a medical procedure, so the person holding the syringe needs a licence that covers medical procedures.
An esthetician licence fails both tests, and it fails them by design. It is issued by a cosmetology or equivalent board, not a medical board, and the practice it authorises is skin-surface work. A healthcare law firm writing on esthetician scope puts the boundary in one line: estheticians “cannot apply dermal fillers or neurotoxins, such as Botox”.
The published surveys of state rules agree without exception. Where they differ is only in how bluntly they say it, and the most direct version is that estheticians and cosmetologists may not inject in any US state, without exception, because injection would constitute the unlicensed practice of medicine.
So there is no state to move to and no certificate to take. A weekend botox training course does not change what your licence is, and several of them are quite careful never to say that it does.
”Under supervision” does not change it, and this is where people get hurt
The most common way this goes wrong is not somebody deciding to break the rule. It is somebody being told, usually by a training provider or an employer, that a physician’s supervision makes it lawful.
Delegation is real and it matters. A physician can delegate medical tasks to people whose own licences let them accept the delegation, which is how RNs, NPs and PAs end up injecting in med spas across the country. What delegation cannot do is hand a task to a licence that does not reach it. A prescriber cannot delegate injecting to an esthetician any more than they could delegate it to a receptionist, because the limit is on the receiving licence rather than on the physician’s generosity.
Two details make this worse than it first looks.
The exposure lands on the individual. If an esthetician injects, it is their licence at risk, and the ordinary consequence of unlicensed medical practice is not a warning. The business has its own exposure, but the person holding the syringe carries the part that ends a career.
The good faith exam is a separate requirement again. Before a first treatment, a prescriber has to evaluate the patient and document the plan. Registered nurses cannot perform it, and neither can estheticians, in any state. A clinic where the injector is also the person who decided the patient should be injected has a second problem on top of the first.
What your licence does cover
The reliable part. Almost everywhere, an esthetician licence covers skin-surface work: facials, cleansing, extractions, waxing, brow and lash work, makeup, and product-led treatments that do not breach living skin.
The useful test underneath all of it is one line, and it is worth memorising because it predicts the answer for treatments this article does not mention. The stratum corneum is the outermost layer of dead skin. Work on or above it tends to be cosmetic. Work that reaches living tissue underneath tends to be medical.
That is not a metaphor. It is close to the line the FDA itself draws on devices, which says that microneedling products “that do not penetrate into the living skin layers (epidermis and dermis)” and claim only to “facilitate exfoliation of the skin (that is, disruption or removal of the stratum corneum)” would generally not be medical devices at all (FDA, Microneedling Devices).
Depth is the variable that decides most of these questions. Not the machine, not the branding, and not the training certificate.
The scope map, in three tiers
Nothing here is legal advice and none of it is settled by us. Scope is set state by state, by boards that change their minds, and the published summaries disagree with each other more than they admit. Treat this as the shape of the question and confirm your own position with your state’s cosmetology board and, where a treatment touches medicine, its medical board too.
| Tier | Treatments usually here | What decides it |
|---|---|---|
| Squarely in scope | Facials, cleansing, extractions, waxing, brow and lash work, makeup, superficial exfoliation, most product-led treatments, LED | Works on or above the stratum corneum, no living tissue reached, no prescription product |
| Conditional, varies by state | Microneedling, chemical peels, dermaplaning, most laser and light-based devices, some advanced modalities | Depth, device classification, whether the state has a separate advanced or master licence, whether physician delegation is permitted and on what terms |
| Never in scope | Botox and other neurotoxins, dermal fillers, any injection, prescription-strength products, anything requiring a prescriber’s order | The licence does not reach medical procedures, and no amount of supervision extends it |
The middle tier is the whole subject. The top tier is why nobody argues, and the bottom tier is why people get into trouble.
Can estheticians do microneedling?
This is the genuinely variable one, and the answer really does depend on where you are.
The federal position is about devices rather than people, but it sets the frame. Since a final guidance process completed by 2020, microneedling devices intended for aesthetic use are regulated as Class II medical devices where they penetrate living skin. Devices that only disrupt the stratum corneum are generally not devices at all. So the same treatment name covers two different legal objects depending on how deep it goes.
States have taken that in different directions, and the published guides put them roughly like this:
- Utah permits master estheticians up to a stated depth
- Arizona limits estheticians to shallow depths, with deeper work reserved for medical personnel
- Texas permits it under physician delegation in a medical setting
- California does not permit estheticians to penetrate the skin
- Florida treats it as bodily intrusion outside cosmetology scope
- Louisiana is reported as prohibiting it even under medical supervision
Those come from industry compilations rather than from the boards themselves, and compilations in this area go stale. Check your own board directly before you buy a device, because the order of operations people regret is buying the machine first.
The practical read: if a device is set shallow enough to be exfoliation, it is probably within an esthetician’s scope in most places. Once it reaches living tissue it becomes a medical procedure in most places, and then the question is not what your licence allows but whose licence is doing it and under what supervision.
What a “medical esthetician” actually is
Worth being direct, because a lot of people believe they hold a credential they do not.
No state officially recognises the title. ByrdAdatto, a healthcare law firm, is explicit that using it “can trigger allegations of unlicensed medical practice”, and their practical advice to med spa owners is to standardise on “licensed esthetician” instead and review marketing materials accordingly.
What the phrase usually describes is a licensed esthetician who works in a medical setting, or who has taken additional private training. Neither changes the licence. And here is the part that matters commercially: working inside a medical practice does not expand an esthetician’s scope. The same firm makes that point plainly. The setting is not the authority.
So “medical esthetician” on your website is a marketing term describing a real person with a real licence and an unreal title. The risk is not the words themselves, it is what a regulator infers a client was led to believe.
Master esthetician is different, and it is real. A minority of states issue an advanced or master esthetics licence with a genuinely wider scope, and where it exists it is the thing that unlocks part of the middle tier. If your state has one, it is the highest-value credential available to you. If it does not, no private certificate substitutes for it.
Chemical peels, lasers and the rest of the middle tier
The same logic, applied.
Chemical peels are usually judged on depth and on the acid and concentration used. Superficial peels are commonly within scope; medium and deep peels reach living tissue and generally are not. The product’s strength is doing the work in that sentence, not the word “peel”.
Lasers and light-based devices vary more than anything else in this article. Some states license laser operation separately, some fold it into esthetics, some treat it as the practice of medicine outright. Where a separate laser licence exists, that is the answer. Where it does not, assume nothing.
Dermaplaning sits close to the line by design, since it is exfoliation performed with a blade, and states differ on whether the blade changes the character of the act.
In all three, the question to ask your board is not “can estheticians do X”. It is “at what depth, with what product, and under whose supervision does X stop being cosmetic in this state”.
What actually happens when scope is exceeded
Not dramatic, mostly, and that is the problem. It rarely announces itself.
The common route is not a raid. It is a complaint, from a client with a poor outcome, or from a competitor who has noticed your service menu. What follows is a board inquiry, and boards ask for records rather than opinions.
The consequences split unevenly, which is the part worth knowing before you agree to anything:
The individual carries the licence risk. Practising outside scope is a matter for the esthetician’s own board, and unlicensed practice of medicine is a matter that can go further than a board. An employer’s instruction is not a defence.
The business carries the rest. Advertising a service it cannot lawfully deliver, supervision arrangements that do not hold up, and the ordinary commercial damage of a service line that has to stop.
The uncomfortable version, and the reason this article exists: the pressure to cross the line almost never comes from ambition. It comes from a booked client, an injector who is not in today, and a treatment room that is otherwise empty.
What those treatments are actually worth
The scope map reads as a list of restrictions because that is how the question is usually asked. Turned around, it describes a service menu that most estheticians are underusing, and the industry’s own numbers say the money is not where people assume.
One 2026 analysis of esthetician service menus puts the highest revenue per hour in the least glamorous places: dermaplaning at $85 to $150 for thirty to forty-five minutes, chemical peels at $120 to $250, and express facials at $65 to $95 as the gateway that drives upgrades. Signature facials sit at $120 to $175. LED is an equipment-led add-on at $25 to $75 with almost no ongoing cost. Microcurrent runs $100 to $175 and sells as a series.
Two findings in that same analysis are worth more than the price list. Acne treatment plans at $400 to $800 across four to six sessions are among the strongest retention products available to an esthetician, because they convert a walk-in into a course of treatment. And scalp treatments at $75 to $120 are called out as an emerging niche with less competition, which matters later in this article for a reason that is not obvious yet.
The structural point underneath: roughly 70 to 80% of revenue typically comes from three to five core treatments, and menus longer than eight to fifteen services tend to work against profitability. Figures from SpaSphere’s 2026 service analysis, which is an industry publication rather than a survey, so treat the numbers as indicative of the shape rather than as your local market.
Which reframes the whole scope question. The problem for most estheticians is not that botox is out of reach. It is that the treatments already in reach are underpriced, undersold as courses, and spread across a menu too long to be good at any of them.
The treatments you cannot perform can still be yours to offer
Here is the part the scope map genuinely does not answer, and the reason it is worth separating what you may perform from what your business may offer.
A prescription program does not need you to prescribe. It needs a clinician to prescribe, a pharmacy to dispense, and somebody the client already trusts to be the reason they started. That last part is the one an esthetician already has and a telehealth brand spends heavily to buy.
Four programs run this way today, and the fit with an esthetics client list is closer than it first looks:
Hair and scalp. The largest natural adjacency, and the one most estheticians never connect to their own chair. Around thirty million American women have androgenetic alopecia, and the widening part line is usually noticed by whoever is working on their head long before a doctor’s office sees it. The prescription stack includes topical and low-dose oral minoxidil, spironolactone and topical finasteride for women, finasteride and minoxidil for men, and prescription scalp topicals and antifungals where a scalp condition needs one. Read that next to the scalp treatments you may already perform, which the industry calls a growth niche with little competition, and the two halves are obviously one service.
Menopause and hormone health. Estradiol, micronized progesterone and related therapies. Hair thinning and skin change are frequently the first symptoms a woman says out loud, and she often says them to you rather than to a doctor.
Medical weight loss. GLP-1 therapy, semaglutide and tirzepatide. Your clients are being sold this everywhere. The rapid weight loss also drives the shedding that lands on your floor, which is why the hair conversation and the weight conversation are the same conversation.
Anti-aging and longevity. NAD+, sermorelin, glutathione and vitamin B12.
The formulary expands over time, and new categories get added as the clinical side supports them, so the list above is where it stands rather than where it stops.
What none of this changes is the scope map. You are not performing these treatments. An independent clinician decides whether each client is a candidate and writes the prescription, a licensed pharmacy dispenses, and you keep doing the work your licence covers. The service is offered under your brand and the client stays yours, which is precisely the thing referring out costs you.
Three ways to add what you cannot perform
Whichever programs you choose, there are only three structures, in ascending order of how much you keep.
Refer out. Simple, and you lose the relationship and the revenue at the moment the client is most willing to spend.
Employ or contract a clinician. You keep the client and the revenue, and you take on recruitment, a salary before the demand exists, the supervision arrangement, and the ownership questions that come with delivering medical services yourself. We have written about who may own what in who can open and own a medical spa, and about the cost and the failure modes in how to find a medical director for a med spa.
Use a program where the clinical side already exists. An independent medical group holds the prescribing and the clinical responsibility, you hold the client relationship and the brand.
Which is right depends on how much of your revenue the medical services would be, and how much fixed cost you can carry before they arrive. That is a business question, and the scope map does not answer it.
Where we sit
The third of those is what we do, and it is worth being precise about the limits, because this article is about scope and it would be easy to imply we solve more of it than we do.
SPA Healthcare is a Local Healthcare program. The clinician is Beluga Health, an independent physician-led medical group licensed in all fifty states. They evaluate the client, they decide whether treatment is appropriate, and not everyone qualifies. Local Healthcare provides the platform. We do not practise medicine, do not make prescribing decisions and do not decide who is a candidate. Compounded medications are prepared by state licensed pharmacies, are not FDA approved, and we make no claim that any compounded preparation is as safe or as effective as any branded alternative.
What this is not: it is not botox, it is not injectables, and it is not a route to performing any treatment in the middle tier above. It does not supervise your aesthetic services, it does not extend your licence, and it does not make an out-of-scope treatment in-scope. It is a set of prescription programs, delivered under your brand by clinicians who are not you, in the four areas above.
If your question was whether there is a way to add botox to what you personally perform, the honest answer is that there is not, and anyone selling you one is selling you a problem. If the question underneath it was how to earn more from the clients you already have, that one has several answers, and most of them are above.
On pricing, the Local Healthcare platform fee is $50 per treatment per month. Medication and fulfilment are billed at cost and quoted directly, because pharmacy product pricing varies by product, strength and pharmacy, and any figure printed here would be wrong for most partners.
The partner sells the program to their client; Local Healthcare provides the platform and collects payment as the partner’s billing agent; the clinician is independent.
Any figures shown are illustrative, not a promise of income. What a partner earns depends on the retail price it sets, its patient volume and retention. The partnership agreement is the controlling document.
Availability varies by state.
How current this is
Checked on 10 September 2026 against: the FDA’s own page on microneedling devices for the stratum corneum distinction and the device boundary; the American Med Spa Association for the Class II classification; ByrdAdatto, January 2025, for esthetician scope inside a medical practice and for the status of the “medical esthetician” title; Little Health Law, March 2026, for the neurotoxin and filler boundary; and published state compilations for the microneedling positions, which are named as compilations in the text because that is what they are.
This article is general information about how scope of practice is structured. It is not legal advice. Scope is set state by state, by boards that revise it, and the secondary compilations that summarise it go out of date quietly. Nothing here should be relied on for your own practice. Confirm it with your state’s cosmetology board, and where a treatment touches medicine, with its medical board and a healthcare attorney licensed where you work.